CAS 1489389-18-5

Formule : C16H16F3N7O

InChI : InChI=1S/C16H16F3N7O/c17-16(18,19)12-8-25-14(26-15-9-22-10(4-20)5-24-15)3-13(12)23-7-11-6-21-1-2-27-11/h3,5,8-9,11,21H,1-2,6-7H2,(H2,23,24,25,26)/t11-/m1/s1

Code InChI : YBYYWUUUGCNAHQ-LLVKDONJSA-N

SMILES : C1CO[C@H](CN1)CNC2=CC(=NC=C2C(F)(F)F)NC3=NC=C(N=C3)C#N

CCT245737

CAS : 1489389-18-5

CCT245737

Formule : C₁₆H₁₆F₃N₇O

Degré de pureté : ≥95%

Masse moléculaire : 379.34

Ref: 54-BUP12330

CCT245737

CAS : 1489389-18-5

CCT245737 is an orally active, selective Chk1 inhibitor, and is >1,000-fold selective over CHK2 and CDK1.Cost-effective and quality-assured.

Formule : C₁₆H₁₆F₃N₇O

Degré de pureté : 98.28% - 99.93%

Couleur et forme : Solid

Masse moléculaire : 379.3397

Ref: TM-T7080

CCT245737

CAS : 1489389-18-5

(R)-5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile

Formule : C₁₆H₁₆F₃N₇O

Degré de pureté : 97+%

Masse moléculaire : 379.34

Ref: IN-DG759805

CCT245737

CAS : 1489389-18-5

CCT245737 is a novel compound that has shown antitumor activity in colorectal adenocarcinoma cells. The compound induces caspase-independent cell death by activating the death protein. CCT245737 also exhibits chemoresistance and kinase selectivity, which makes it an attractive candidate for the treatment of cancer.

Formule : C₁₆H₁₆F₃N₇O

Degré de pureté : Min. 95%

Masse moléculaire : 379.34 g/mol

Ref: 3D-PJC38918

CCT245737

CAS : 1489389-18-5

Formule : C₁₆H₁₆F₃N₇O

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 379.3397

Ref: IN-DA00ABR8